A detailed history of Sound Income Strategies, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sound Income Strategies, LLC holds 127 shares of CRSP stock, worth $5,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127
Previous 127 -0.0%
Holding current value
$5,878
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$60.67 - $89.12 $303 - $445
-5 Reduced 3.79%
127 $8,000
Q4 2023

Jan 10, 2024

BUY
$38.62 - $72.18 $193 - $360
5 Added 3.94%
132 $8,000
Q1 2022

Apr 11, 2022

SELL
$53.19 - $79.24 $17,605 - $26,228
-331 Reduced 72.27%
127 $8,000
Q4 2021

Jan 13, 2022

SELL
$70.09 - $111.29 $1,121 - $1,780
-16 Reduced 3.38%
458 $35,000
Q2 2021

Jul 13, 2021

BUY
$100.84 - $161.89 $34,991 - $56,175
347 Added 273.23%
474 $77,000
Q1 2021

Apr 14, 2021

BUY
$110.72 - $210.04 $14,061 - $26,675
127 New
127 $15,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Sound Income Strategies, LLC Portfolio

Follow Sound Income Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.